Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CVX vs GSK✓SelectedUSD · GSKCVX vs GSK performance historyLatest closeAs of-3.95%11/18
Stock and ETF performance explorer

CVX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+38.9%
GSK return
+7.0%
Excess return
+31.9%
Maximum drawdown
-20.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.0%-1.3%-2.6%-4.1%
7D-2.7%-3.1%+0.5%-3.0%
30D-7.5%-0.9%-6.6%-7.5%
3M+1.8%-4.2%+5.9%+1.5%
6M+7.7%-1.6%+9.3%+7.9%
YTD+40.0%+2.6%+37.4%+38.7%
1Y+38.9%+6.2%+32.7%+36.9%
All+38.9%+7.0%+31.9%+36.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling